Giulio Superti-Furga

Giulio Superti-Furga, PhD (* 17 May 1962 in Milan) is an Italian molecular and systems biologist based in Vienna, Austria.

Giulio Superti-Furga is the Scientific Director of CeMM; the Research Center for Molecular Medicine of the Austrian Academy of Sciences.

Amongst his most significant scientific achievements to date are the elucidation of basic regulatory mechanisms of tyrosine kinases in human cancers and the discovery of fundamental organization principles of the proteome of higher organisms, which is one of the most highly cited papers in the field. His work has directly contributed to a systems-level understanding of pathogen infections in host cells and of the mechanism of action of specific drugs. He is an advocate for the adoption of systems biology approaches for medicine and in particular for drug discovery and aims to bridge basic research and the clinical world.

Giulio Superti-Furga has published some 90 manuscripts that have been collectively cited over 7,000 times. His current work focuses on protein complexes, molecular networks and drugs relevant for leukemia and host immune defense mechanisms against pathogens.

CV

Giulio Superti-Furga was educated at the German School of Milan (DSM) in Milan, Italy. He performed his undergraduate and graduate studies in Molecular Biology at the University of Zurich, at Genentech Inc. in San Francisco and at the Research Institute of Molecular Pathology (IMP) in Vienna. Giulio Superti-Furga was a post-doctoral fellow at the European Molecular Biology Laboratory (EMBL) in Heidelberg and became Team Leader in 1995. From 1997 to 2000 he served as Guest Professor of Molecular Biology at the University of Bologna, Italy. In 2000, he co-founded the biotech company Cellzome Inc. and served as Scientific Director. Since 2005 he has been Scientific Director of CeMM; the Research Center for Molecular Medicine of the Austrian Academy of Sciences. Giulio Superti-Furga is a Visiting Professor of Molecular Pharmacology at the Medical University of Vienna and is on the Scientific Advisory Board of several institutions. Giulio Superti-Furga chairs the board of the EMBL Alumni Association, which has ~1,500 members. In 2009, he was awarded the Knight Officer Order of Merit of the Republic of Italy for his contributions to science. He is married and has two children.

Honors

• 2004: Faculty of 1000 Biology, member, genomics section
• 2005: European Molecular Biology Organization (EMBO), member
• 2007: Austrian Academy of Sciences, corresponding member
• 2008: German Academy of Sciences Leopoldina, member
• 2009: Order of Merit of the Republic of Italy, Knight Officer
• 2009: Karl Landsteiner Prize by the Austrian Society of Allergology and Immunology
• 2009: Advanced Investigator Grant of the European Research Council
• 2010: Fellow of the European Academy of Cancer Sciences
• 2010: Austrian Academy of Sciences, full member
• 2011: Research Prize of the City of Vienna
• 2011: Austrian Scientist of the Year 2011

References

(selected)

• Gavin, A.C. et al. Nature. 2002; 415:141–147.
• Pluk, H. et al. Cell. 2002; 108:247–259.
• Hantschel, O. et al. Cell. 2003; 112:845–857.
• Brown, D. and Superti-Furga, G. Drug Discovery Today. 2003; 8:1067–1077.
• Bouwmeester, T. et al. Nature Cell Biology. 2004; 6:97–105.
• Gavin, A.C. et al. Nature. 2006; 440(7084):631-6.
• Burckstummer, T. et al. Nat Methods. 2006; 3(12):1013-9.
• Kocher, T. and Superti-Furga, G. Nat Methods. 2007; 4(10):807-15.
• Rix, U. et al. Blood 2007; 110(12):4055-63
• Henney, A. and Superti-Furga, G. Nature. 2008; 455(7214):730-1
• Bürckstümmer, T. et al. Nat Immunol. 2009; 10(3):266-72
• Brehme, M., Hantschel, O. et al. Proc Natl Acad Sci U S A. 2009; 106(18):7414–9
• Rix, U. et al. Leukemia, 2010, 24: 44–50
• Baumann, C. et al. J Exp Med, 2010, 207(12): 2689-701.
• Pichlmair, A. et al. Nat Immunol, 2011, 12(7):624-30.
• Grebien, F. et al. Cell, 2011, 147(2):306-19

External links

• CeMM – Research Center of Molecular Medicine
• Austrian Academy of Sciences
• Cellzome, Inc.
• German Academy of Sciences Leopoldina
• Medical University of Vienna
• Research Institute of Molecular Pathology
• European Molecular Biology Laboratory
• EMBO Members
• Faculty of 1000 Biology